Trial intelligence / Profile preview

The Influence of Intranasal Oxytocin on Communication

NCT02415920Completed

Sponsor
University of British Columbia
Start
Nov 2017
Primary completion
Dec 2018
Countries
1
01

Overview

Randomised trial of oxytocin nasal spray (2 arms), sponsored by University of British Columbia. Primary endpoint: Communication Outcomes. Started Nov 2017; status: completed.

02

Drugs

oxytocin nasal spray

Beyond the preview

Go deeper on NCT02415920.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02415920.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call